Pfizer Inc. (NYSE:PFE) is expecting results on two different clinical trials of treatment, which it hopes will help the company make up for the billions of dollars it lost in revenue in the past few years. Pfizer Inc. (NYSE:PFE) stock opened at $30.56 in last session, and closed at $30.40, while the day range of PFE stock was $30.21 – $30.66. The stock showed a positive weekly performance of 1.03%.
Merck & Co Inc, (NYSE:MRK) the second largest drug maker in the US, is reported to have received interest from large consumer firms for its consumer healthcare business, a sale that may fetch it between $8 billion to $10 billion. Merck & Co., Inc. (NYSE:MRK) stock opened at $53.31, in last session and closed at $52.97, by losing -1.01%. The 52 week range of MRK is $40.83 – $54.10. Company’s market capitalization is $155.02billion.
AbbVie Inc. (NASDAQ:ABBV) updated its FY14 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $3.00-3.10 for the period, compared to the Thomson Reuters consensus estimate of $3.16, AnalystRatingsNetwork reports. AbbVie Inc (NYSE:ABBV) stock advanced 1.90% and finished the last session at $49.23. The EPS of the stock remained 2.85. Company’s market capitalization is $78.17billion.
The pharmaceutical giant Johnson & Johnson (NYSE:JNJ) has agreed to share all of its clinical trial data with the Yale Open Data Access Project (YODA), an unprecedented agreement that will provide researchers across the globe with a trove of information about drug development and disease. Johnson & Johnson (NYSE:JNJ) stock opened the session at $89.01, and closed the session at $88.47. The 52 week range of the JNJ stock remained $73.56 – $95.99 and the day range was $88.15 – $89.34.